Evotec, Sanofi on Infectious Disease Research Agreement
The Pharmaceutical Business Review website reported that the major drug companies Evotec and Sanofi are in exclusive negotiations to create an infectious disease open innovation research and development platform through a new open innovation platform near Lyon in France. The platform will be led by Evotec for which Sanofi will license more than ten of its infectious disease research and early-stage development portfolio. Evotec will run the open innovation platform near Lyon, France. Sanofi will also transfer its infectious disease research unit to Evotec as part of the proposed transaction. The platform will be open for collaborations with other pharmaceutical and biotechnology firms, academia, foundations, and government agencies.
Click here to read the full article.
.
Image via Flickr.